June 23, 2021 - … today issued the following statement: On June 7, 2021, ADUHELM™ (aducanumab-avwa) 100 mg/mL solution for injection … and providing more details about our plans. About ADUHELM treatment and the confirmatory trial ADUHELM is indicated for the treatment of Alzheimer’s …